A double-blind randomized controlled trial of continuous intravenous Ketorolac vs placebo for adjuvant pain control after renal surgery
- PMID: 23058854
- PMCID: PMC3532697
- DOI: 10.1016/j.mayocp.2012.07.018
A double-blind randomized controlled trial of continuous intravenous Ketorolac vs placebo for adjuvant pain control after renal surgery
Abstract
Objective: To evaluate the efficacy and safety of a novel, continuous intravenous infusion of ketorolac, a powerful nonopioid analgesic, for postoperative pain control.
Patients and methods: A prospective, double-blind, randomized, placebo-controlled trial of a continuous infusion of ketorolac tromethamine in 1 L of normal saline vs placebo was performed in 135 patients aged 18 to 75 years after laparoscopic donor nephrectomy or percutaneous nephrolithotomy completed from October 7, 2008, through July 21, 2010. Primary study end points were the 24-hour differences in visual analog pain scores and total narcotic consumption, whereas secondary end points were differences in urine output, serum creatinine level, and hemoglobin level.
Results: The study was stopped after randomization of 135 patients (68 in the ketorolac group and 67 in the placebo group) when interim analysis indicated that the difference in mean pain scores between the 2 groups (difference, 0.6) was smaller than the 1-point threshold set forth in the power calculations. No statistically significant change was noted in hemoglobin levels from preoperative to postoperative values (P=.13) or in postoperative serum creatinine levels (P=.13).
Conclusion: Although continuous infusion of ketorolac produced only a modest decrease in the use of narcotics, it appears to offer a safe therapeutic option for nonnarcotic pain control.
Trial registration: clinicaltrials.gov Identifiers: NCT00765128 and NCT00765232.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Intraoperative ketorolac and eye pain after viteoretinal surgery: a prospective, randomized, placebo-controlled study.Retina. 2003 Feb;23(1):8-13. doi: 10.1097/00006982-200302000-00002. Retina. 2003. PMID: 12652225 Clinical Trial.
-
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial.Arch Ophthalmol. 2008 Sep;126(9):1203-8. doi: 10.1001/archopht.126.9.1203. Arch Ophthalmol. 2008. PMID: 18779478 Clinical Trial.
-
A randomized, controlled trial to compare ketorolac tromethamine versus placebo after cesarean section to reduce pain and narcotic usage.Am J Obstet Gynecol. 2003 Dec;189(6):1559-62; discussion 1562. doi: 10.1016/j.ajog.2003.08.014. Am J Obstet Gynecol. 2003. PMID: 14710063 Clinical Trial.
-
Ketorolac for early postoperative analgesia.J Clin Anesth. 1995 Sep;7(6):465-9. doi: 10.1016/0952-8180(95)00054-l. J Clin Anesth. 1995. PMID: 8534461 Clinical Trial.
-
A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model.Clin Ther. 2001 Jul;23(7):1018-31. doi: 10.1016/s0149-2918(01)80088-6. Clin Ther. 2001. PMID: 11519767 Clinical Trial.
Cited by
-
Effects of peri-operative nonsteroidal anti-inflammatory drugs on post-operative kidney function for adults with normal kidney function.Cochrane Database Syst Rev. 2018 Nov 29;11(11):CD011274. doi: 10.1002/14651858.CD011274.pub2. Cochrane Database Syst Rev. 2018. PMID: 30488949 Free PMC article.
-
The Combination of Ketorolac with Local Anesthesia for Pain Control in Day Care Retinal Detachment Surgery: A Randomized Controlled Trial.J Ophthalmol. 2017;2017:3464693. doi: 10.1155/2017/3464693. Epub 2017 Jul 9. J Ophthalmol. 2017. PMID: 28770108 Free PMC article.
-
A Single Perioperative Injection of Dexamethasone Decreases Nausea, Vomiting, and Pain after Laparoscopic Donor Nephrectomy.J Transplant. 2017;2017:3518103. doi: 10.1155/2017/3518103. Epub 2017 Jan 22. J Transplant. 2017. PMID: 28210502 Free PMC article.
-
Laparoscopic surgery: a narrative review of pharmacotherapy in pain management.Drugs. 2015 Nov;75(16):1867-89. doi: 10.1007/s40265-015-0482-y. Drugs. 2015. PMID: 26493289 Review.
-
Pain management in neurocritical care.Neurocrit Care. 2013 Oct;19(2):232-56. doi: 10.1007/s12028-013-9851-0. Neurocrit Care. 2013. PMID: 23893074 Review.
References
-
- Palvin D.J., Chen C., Penaloza D.A., Polissar N.L., Buckley F.P. Pain as a factor complicating recovery and discharge after ambulatory surgery. Anesth Analg. 2002;95(3):627–634. - PubMed
-
- Knight M.K., DiMarco D.S., Myers R.P. Subjective and objective comparison of critical care pathways for open donor nephrectomy. J Urol. 2002;167(6):2368–2371. - PubMed
-
- Carr D.B., Jacox A.K., Chapman C.R. Acute Pain Management: Operative or Medical Procedures and Trauma: Clinic Practice Guideline. Agency for Health Care Policy and Research, Public Health Service, US Dept of Health and Human Services; Rockville, MD: 1992.
-
- Ready L.B., Brown C.R., Stahlgren L.H. Evaluation of intravenous ketorolac administered by bolus or infusion for treatment of postoperative pain: a double-blind, placebo-controlled, multicenter study. Anesthesiology. 1994;80(6):1277–1286. - PubMed
-
- Breda A., Bui M., Liao J., Schulam P.G. Association of bowel rest and ketorolac analgesia with short hospital stay after laparoscopic donor nephrectomy. Urology. 2007;69(5):828–831. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
